Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078000 | SCV000109838 | pathogenic | not provided | 2013-07-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003495109 | SCV004275376 | pathogenic | Mucopolysaccharidosis type 6 | 2023-06-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 92353). This variant has not been reported in the literature in individuals affected with ARSB-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly40Profs*81) in the ARSB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSB are known to be pathogenic (PMID: 17458871, 22133300). |
Baylor Genetics | RCV003495109 | SCV005055436 | likely pathogenic | Mucopolysaccharidosis type 6 | 2024-03-20 | criteria provided, single submitter | clinical testing |